Trial intelligence / Profile preview

OPC-41061 for treatment of cardiac edema in congestive heart failure

jRCT2080220442Phase 3

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tolvaptan in heart failure (HF) and edema secondary to heart failure, sponsored by Otsuka Pharmaceutical Co., Ltd.

02

Drugs

tolvaptan
03

Conditions

heart failure (HF)edema secondary to heart failure

Beyond the preview

Go deeper on jRCT2080220442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call